Similarly, of the 34 patients with significant CE findings P2, 16 47% had no recurrence of bleeding during follow-up, 15 44% had iron deficiency anemia, and only 3 9% had obvious recurrent bleeding.
Del mismo modo, de los 34 pacientes con hallazgos significativos P2 en CE, 16 47% no presentaron recurrencia de sangrado durante el seguimiento, 15 44% presentaron anemia ferropénica, y solo 3 9% tuvieron sangrado evidente recurrente.